Literature DB >> 12706458

Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents.

Atticus H Hainsworth1, Nicolle C L McNaughton, Alexey Pereverzev, Toni Schneider, Andrew D Randall.   

Abstract

Relatively little has been published on the pharmacology of R-type and T-type Ca(2+) channels. Here, whole-cell Ca(2+) channel currents were recorded from human embryonic kidney 293 cell-lines transfected with either alpha1E subunits (R-type currents) or alpha1G or alpha1I subunits (T-type currents). R-type currents were inhibited by sipatrigine and the related compound 202W92 (R-(-)-2,4-diamino-6-(fluromethyl)-5-(2,3,5-trichlorophenyl)pyrimidine) with IC(50) 10 and 56 microM, respectively. A therapeutic concentration of lamotrigine (10 microM) inhibited R-type currents (30%) but was without effect on alpha1I-mediated T-type currents. Lamotrigine was also a weak inhibitor of T-type currents mediated by alpha1G subunits (<10% inhibition by 100 microM).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706458     DOI: 10.1016/s0014-2999(03)01625-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

Review 1.  T-type calcium channel blockers as neuroprotective agents.

Authors:  Benjamin J Kopecky; Ruqiang Liang; Jianxin Bao
Journal:  Pflugers Arch       Date:  2014-02-25       Impact factor: 3.657

Review 2.  The potential role of lamotrigine in schizophrenia.

Authors:  Charles H Large; Elizabeth L Webster; Donald C Goff
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

3.  Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications.

Authors:  David S Auerbach; Yitschak Biton; Bronislava Polonsky; Scott McNitt; Robert A Gross; Robert T Dirksen; Arthur J Moss
Journal:  Transl Res       Date:  2017-10-20       Impact factor: 7.012

Review 4.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

5.  Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.

Authors:  Erin E Gray; Jonathan G Murphy; Ying Liu; Ivan Trang; G Travis Tabor; Lin Lin; Dax A Hoffman
Journal:  J Neurosci       Date:  2019-07-26       Impact factor: 6.167

6.  De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias.

Authors:  Katherine L Helbig; Robert J Lauerer; Jacqueline C Bahr; Ivana A Souza; Candace T Myers; Betül Uysal; Niklas Schwarz; Maria A Gandini; Sun Huang; Boris Keren; Cyril Mignot; Alexandra Afenjar; Thierry Billette de Villemeur; Delphine Héron; Caroline Nava; Stéphanie Valence; Julien Buratti; Christina R Fagerberg; Kristina P Soerensen; Maria Kibaek; Erik-Jan Kamsteeg; David A Koolen; Boudewijn Gunning; H Jurgen Schelhaas; Michael C Kruer; Jordana Fox; Somayeh Bakhtiari; Randa Jarrar; Sergio Padilla-Lopez; Kristin Lindstrom; Sheng Chih Jin; Xue Zeng; Kaya Bilguvar; Antigone Papavasileiou; Qinghe Xing; Changlian Zhu; Katja Boysen; Filippo Vairo; Brendan C Lanpher; Eric W Klee; Jan-Mendelt Tillema; Eric T Payne; Margot A Cousin; Teresa M Kruisselbrink; Myra J Wick; Joshua Baker; Eric Haan; Nicholas Smith; Azita Sadeghpour; Erica E Davis; Nicholas Katsanis; Mark A Corbett; Alastair H MacLennan; Jozef Gecz; Saskia Biskup; Eva Goldmann; Lance H Rodan; Elizabeth Kichula; Eric Segal; Kelly E Jackson; Alexander Asamoah; David Dimmock; Julie McCarrier; Lorenzo D Botto; Francis Filloux; Tatiana Tvrdik; Gregory D Cascino; Sherry Klingerman; Catherine Neumann; Raymond Wang; Jessie C Jacobsen; Melinda A Nolan; Russell G Snell; Klaus Lehnert; Lynette G Sadleir; Britt-Marie Anderlid; Malin Kvarnung; Renzo Guerrini; Michael J Friez; Michael J Lyons; Jennifer Leonhard; Gabriel Kringlen; Kari Casas; Christelle M El Achkar; Lacey A Smith; Alexander Rotenberg; Annapurna Poduri; Alba Sanchis-Juan; Keren J Carss; Julia Rankin; Adam Zeman; F Lucy Raymond; Moira Blyth; Bronwyn Kerr; Karla Ruiz; Jill Urquhart; Imelda Hughes; Siddharth Banka; Ulrike B S Hedrich; Ingrid E Scheffer; Ingo Helbig; Gerald W Zamponi; Holger Lerche; Heather C Mefford
Journal:  Am J Hum Genet       Date:  2018-10-18       Impact factor: 11.025

Review 7.  Targeting voltage-gated calcium channels in neurological and psychiatric diseases.

Authors:  Gerald W Zamponi
Journal:  Nat Rev Drug Discov       Date:  2015-11-06       Impact factor: 84.694

Review 8.  The Role of Calcium Channels in Epilepsy.

Authors:  Sanjeev Rajakulendran; Michael G Hanna
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-04       Impact factor: 6.915

9.  Review: Cav2.3 R-type Voltage-Gated Ca2+ Channels - Functional Implications in Convulsive and Non-convulsive Seizure Activity.

Authors:  Carola Wormuth; Andreas Lundt; Christina Henseler; Ralf Müller; Karl Broich; Anna Papazoglou; Marco Weiergräber
Journal:  Open Neurol J       Date:  2016-09-30

10.  How "Pharmacoresistant" is Cav2.3, the Major Component of Voltage-Gated R-type Ca2+ Channels?

Authors:  Toni Schneider; Maxine Dibué; Jürgen Hescheler
Journal:  Pharmaceuticals (Basel)       Date:  2013-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.